SCHEMBL29100732

SCHEMBL29100732

O=c1[nH]c2nccc(Br)c2[nH]c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DAO P14920 6/20 1.00
PRKCI P41743 1/20 0.41
AURKA O14965 3/20 0.39
PARP1 P09874 1/20 0.39
AURKB Q96GD4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29701766 1.00 DAO (1.00) DAOPRKCIAURKAPARP1AURKB
SCHEMBL29544574 0.84 DAO (0.72) DAOPRKCIAURKAAURKB
SCHEMBL19876250 0.84 DAO (0.72) DAOPRKCIAURKAAURKB
SCHEMBL1135576 0.76 DAO (0.61) DAOAURKAPARP1AURKB
SCHEMBL8483100 0.76 DAO (0.61) DAOAURKAPARP1
SCHEMBL9909699 0.72 DAO (0.56) DAOAURKAPARP1AURKB
SCHEMBL8483308 0.69 DAO (0.53) DAO
SCHEMBL9909765 0.68 BRAF (0.57) DAOAURKA
SCHEMBL15566518 0.68 DAO (0.52) DAO
SCHEMBL30055673 0.65 DAO (0.49) DAOPRKCIAURKAPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116981667-A Heterocyclic inhibitors of EGFR and/or HER2 for cancer treatment 蝎子疗法股份有限公司 2023-10-31 CN disclosed